Prostate Cancer

Advances in Targeted Therapy for Metastatic Prostate Cancer. April 30, 2025

Pelvic lymph node dissection in prostate cancer - is it really necessary? A multicentric longitudinal study assessing oncological outcomes in prostate cancer patients undergoing pelvic lymph node dissection vs radical prostatectomy only. April 30, 2025

6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancer. April 30, 2025

Advances in Current Treatment Paradigms for Metastatic Hormone-Sensitive Prostate Cancer. April 30, 2025

The Influence of the Germline HSD3B1 Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer. April 30, 2025

Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer. April 30, 2025

Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity. April 30, 2025

Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotactic Ablative Body Radiotherapy. April 29, 2025

Optimizing biopsy decisions in PI-RADS 3 lesions: cross-institutional validation of a local clinical risk model. April 29, 2025

Trends in Surgical Overtreatment of Prostate Cancer. April 29, 2025

Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers. April 29, 2025

Salvage Radiosurgery After Brachytherapy for Locally Recurrent Prostate Cancer With Real-Time Adaptive Motion Management Using Previously Implanted Brachytherapy Seeds as Fiducial Markers. April 29, 2025

Optimizing therapy for high-risk biochemically recurrent non-metastatic prostate cancer: Current and emerging strategies. April 28, 2025

Individuals from culturally and linguistically diverse backgrounds have more advanced prostate cancer at diagnosis in Victoria, Australia. April 28, 2025

Long-term outcomes of radiotherapy and impact of nodal disease burden in clinically node-positive prostate cancer. April 28, 2025

Combination metastasis-targeted external beam radiation therapy with 177Lu-PSMA-617 in patients with advanced castration-resistant prostate cancer. April 28, 2025

Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data. April 28, 2025

Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer. April 28, 2025

Sexual activity in men undergoing ADT for localized prostate cancer: a narrative literature review. April 28, 2025

AUA 2025: Testosterone Recovery Following Treatment Suspension of Enzalutamide plus Leuprolide or Leuprolide Alone in Patients with High-Risk Biochemically Recurrent Prostate Cancer: EMBARK Post Hoc Analysis April 27, 2025

Page 1 of 1474